Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.
American Well Corporation, known as Amwell (NYSE: AMWL), regularly issues news and updates about its role in digital care and technology-enabled healthcare. Company announcements highlight its SaaS-based care platform, relationships with payers, health systems and government organizations, and its ongoing work to support digital and hybrid care models.
On this news page, readers can follow Amwell’s earnings announcements and quarterly operating updates, which are often accompanied by investor conference calls and webcasts. The company frequently reports the timing of its financial results, provides access details for live audio webcasts and notes the availability of replay links through its investor resources.
Amwell’s news flow also covers commercial partnerships and contracts. For example, the company has reported on its role in the U.S. Defense Health Agency’s Digital First Program for the Military Health System, where its technology-enabled care platform powers virtual visits integrated with the MHS GENESIS electronic health record. News items describe how the platform supports military care teams, service members and their families across the global Department of Defense enterprise.
Investors and observers can also see updates on Amwell’s agreements with Elevance Health related to the LiveHealth Online white‑label digital care platform, as well as disclosures about equity inducement grants to new employees under its inducement plan. Together, these items provide insight into Amwell’s operational priorities, customer relationships and use of technology to support digital care programs.
For anyone tracking AMWL, this news feed brings together company-issued releases on financial results, major contracts, investor conference participation and corporate actions, offering a centralized view of Amwell’s public communications about its technology-enabled care business.
Amwell (NYSE: AMWL) will report fourth quarter and full year 2025 operating results after market close on Thursday, Feb. 12, 2026. Management will host a live conference call and webcast at 5:00 p.m. ET to review results and provide a business update.
The full earnings release and live audio webcast will be available in the company's Investors section; a webcast replay will remain available at investors.amwell.com for approximately 90 days.
Amwell (NYSE: AMWL) announced financial results for the third quarter ended September 30, 2025. The company said its full third quarter earnings report is available at investors.amwell.com.
Amwell will host a conference call to discuss results on November 4, 2025 at 5:00 p.m. ET; the call is accessible via live audio webcast at https://edge.media-server.com/mmc/p/63sb3bwu. A webcast replay will be available for approximately 90 days at investors.amwell.com.
Amwell (NYSE: AMWL) will report third quarter 2025 operating results after market close on Tuesday, Nov. 4, 2025. Management will host a live conference call and webcast at 5:00 p.m. ET to review results and provide a business update. The full earnings report and live audio webcast will be available in the company's Investors section, and a webcast replay will remain at investors.amwell.com for about 90 days.
Company executives will attend investor conferences: Mark Hirschhorn, CFO and COO, will hold one-on-one meetings at the UBS Global Healthcare Conference on Nov. 11 in Palm Beach Gardens, FL, and will join a virtual panel titled “Transforming a Sick-Care System into a Health-Care System” at the BTIG Digital Health Forum on Nov. 24 at 8:00 a.m. ET; an audio webcast of the fireside chat will be posted at investors.amwell.com.
Amwell (NYSE: AMWL), a technology-enabled care platform provider, has granted 76,198 Restricted Stock Units (RSUs) of Class A common stock to two new employees as employment inducements. The RSUs follow a four-year vesting schedule, with 25% vesting after one year and the remaining 75% vesting quarterly over three years.
The grants were approved by Amwell's Compensation Committee under the company's Inducement Plan, complying with NYSE's Listed Company Manual Rule 303A.08.
Amwell (NYSE: AMWL), a leading SaaS-based healthcare platform provider, has announced its financial results for the second quarter ended June 30, 2025. The company will discuss these results during a conference call scheduled for 5 p.m. ET on August 5, 2025.
The earnings report is available on the company's investor relations website, and a live audio webcast of the conference call will be accessible online. A replay of the webcast will remain available for approximately 90 days on the investor relations website.
Amwell (NYSE: AMWL) has secured an extension of its Digital First contract as part of a Leidos-led partnership to continue powering the Military Health System's (MHS) digital transformation. The platform serves approximately 9.6 million beneficiaries across the Department of Defense enterprise, including active-duty service members, families, and retirees.
The successfully deployed platform has replaced MHS Video Connect and is fully integrated with MHS GENESIS electronic health record. Key achievements include nearly tripling virtual visits, expansion to U.S. Coast Guard and Military Entrance Processing Command, and enabling successful virtual visits from combat zones to U.S. military hospitals.
Amwell (NYSE: AMWL), a leading SaaS-based healthcare technology platform provider, has scheduled its second quarter 2025 earnings release for August 5 after market close. Management will host a conference call and webcast at 5 p.m. ET to discuss results and provide business updates.
Additionally, company executives will participate in two upcoming investor conferences: CFO/COO Mark Hirschhorn will attend the Wells Fargo Healthcare Conference on September 4 in Boston, while Chairman/CEO Ido Schoenberg and Hirschhorn will join the Morgan Stanley Global Healthcare Conference on September 9 in New York, including a fireside chat at 2:35 p.m. ET.
Amwell (NYSE: AMWL) has granted 3,451 Restricted Stock Units (RSUs) of Class A common stock to a new employee as an employment inducement. The vesting schedule includes 25% of RSUs vesting on the first anniversary of the grant date, with the remaining 75% vesting in equal increments every three months over the following three years. The grant was approved by Amwell's Compensation Committee under the company's Inducement Plan and complies with NYSE's Listed Company Manual Rule 303A.08.
Amwell (NYSE: AMWL), a provider of SaaS-based technology-enabled healthcare platforms, has announced its financial results for the first quarter ending March 31, 2025. The company will host a conference call on May 1, 2025, at 5 p.m. ET to discuss these results. The earnings report can be accessed through Amwell's investor relations website, and the conference call will be available via live audio webcast, with a replay accessible afterward on the investor relations site.
Amwell (NYSE: AMWL), a leading provider of SaaS-based healthcare technology platform, has announced its participation in two major upcoming investor conferences.
Key events include:
- Needham & Co. Virtual Technology and Services Conference on May 8, where CFO and COO Mark Hirschhorn will conduct one-on-one meetings virtually
- Truist Securities Healthcare Disruptors & Digital Health Conference on June 24 in New York City, featuring Mark Hirschhorn's participation
FAQ
What is the current stock price of American Well (AMWL)?
What is the market cap of American Well (AMWL)?
